Copyright
©The Author(s) 2015.
World J Nephrol. May 6, 2015; 4(2): 148-159
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.148
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.148
Comments | |
Potential benefits | |
A failing graft is a focus of a chronic inflammatory state | |
May reduce mortality rates | Variable results, further studies are needed |
Potential adverse effects | |
Residual kidney function may allow less stringent fluid restriction | |
Surgery-related morbidity and mortality | Morbidity 17%-60% in most series reported |
Mortality 1.5%-14% in most series reported | |
Allosensitization and the potential for future prolonged wait-times for a compatible crossmatch kidney | |
Impact on a repeat transplant | |
Mixed reports due to potential confounding factors | |
Differences among studies in: | |
Immunosuppression withdrawal protocols | |
Recipient and donor demographics | |
Era of transplantation | |
Indications for transplantectomy | |
Time on dialysis prior to a repeat transplant | |
Causes of prior graft loss | |
Allosensitization associated with blood transfusion | |
Pre-existing DSA with or without complement-fixing DSA (see text) | |
HLA matching of subsequent graft | |
Donor type (living vs deceased) | |
Others |
- Citation: Pham PT, Everly M, Faravardeh A, Pham PC. Management of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomy. World J Nephrol 2015; 4(2): 148-159
- URL: https://www.wjgnet.com/2220-6124/full/v4/i2/148.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i2.148